Literature DB >> 15133076

Molecular typing of Pneumocystis jirovecii found in formalin-fixed paraffin-embedded lung tissue sections from sudden infant death victims.

M Chabé1, S L Vargas2, I Eyzaguirre2, E M Aliouat1, A Follet-Dumoulin1, C Creusy3, L Fleurisse3, C Recourt1, D Camus4,1, E Dei-Cas4,1, I Durand-Joly4,1.   

Abstract

Previous studies have provided histological evidence of an association between primary Pneumocystis infection and sudden infant death syndrome (SIDS). The aim of this work was to determine the species of clustered Pneumocystis organisms found in formalin-fixed paraffin-embedded (FFPE) lung tissue sections from Chilean sudden infant death (SID) victims. This approach needed first to optimize a DNA extraction method from such histological sections. For that purpose, the QIAamp DNA Isolation from Paraffin-Embedded Tissue method (Qiagen) was first tested on FFPE lung tissue sections of immunosuppressed Wistar rats inoculated with rat-derived PNEUMOCYSTIS: Successful DNA extraction was assessed by the amplification of a 346 bp fragment of the mitochondrial large subunit rRNA gene of the Pneumocystis species using a previously described PCR assay. PCR products were analysed by direct sequencing and sequences corresponding to Pneumocystis carinii were found in all the samples. This method was then applied to FFPE lung tissue sections from Chilean SID victims. Pneumocystis jirovecii was successfully identified in the three tested samples. In conclusion, an efficient protocol for isolating PCR-ready DNA from FFPE lung tissue sections was developed. It established that the Pneumocystis species found in the lungs of Chilean SID victims was P. jirovecii.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133076     DOI: 10.1099/mic.0.26895-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  4 in total

1.  In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.

Authors:  E M Aliouat; E Dei-Cas; N Gantois; M Pottier; C Pinçon; S Hawser; A Lier; D B Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-12       Impact factor: 3.267

2.  SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

Authors:  Annie Standaert-Vitse; Cécile-Marie Aliouat-Denis; Anna Martinez; Sara Khalife; Muriel Pottier; Nausicaa Gantois; Eduardo Dei-Cas; El Moukhtar Aliouat
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

3.  Near-universal prevalence of Pneumocystis and associated increase in mucus in the lungs of infants with sudden unexpected death.

Authors:  Sergio L Vargas; Carolina A Ponce; Miriam Gallo; Francisco Pérez; J-Felipe Astorga; Rebeca Bustamante; Magali Chabé; Isabelle Durand-Joly; Pablo Iturra; Robert F Miller; El Moukthar Aliouat; Eduardo Dei-Cas
Journal:  Clin Infect Dis       Date:  2012-10-16       Impact factor: 9.079

4.  Multilocus Genotyping of Pneumocystis jirovecii from Deceased Cuban AIDS Patients Using Formalin-Fixed and Paraffin-Embedded Tissues.

Authors:  Vicente Friaza; Yaxsier de Armas; Virginia Capó; Rubén Morilla; Arturo Plascencia-Hernández; Héctor R Pérez-Gómez; Enrique Iglesias; Luis Fonte; Carmen de la Horra; Enrique J Calderón
Journal:  J Fungi (Basel)       Date:  2021-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.